Datta, N. (2024). Highlighting the Concerns Surrounding the Recent Outbreak of SARS-CoV-2 Subvariant BA.2.86 (Pirola). Journal of Clinical Research & Bioethics, 0(0), 1–2. https://doi.org/10.35248/2155-9627.24.S18.001
Datta, N. (2024). Highlighting the Concerns Surrounding the Recent Outbreak of SARS-CoV-2 Subvariant BA.2.86 (Pirola). Journal of Clinical Research & Bioethics, 0(0), 1–2. https://doi.org/10.35248/2155-9627.24.S18.001
Datta, N. (2024). Highlighting the Concerns Surrounding the Recent Outbreak of SARS-CoV-2 Subvariant BA.2.86 (Pirola). Journal of Clinical Research & Bioethics, 0(0), 1–2. https://doi.org/10.35248/2155-9627.24.S18.001
Datta, N. (2024). Highlighting the Concerns Surrounding the Recent Outbreak of SARS-CoV-2 Subvariant BA.2.86 (Pirola). Journal of Clinical Research & Bioethics, 0(0), 1–2. https://doi.org/10.35248/2155-9627.24.S18.001
Abstract
The emergence of SARS-CoV-2 subvariant BA.2.86, also known as Pirola, has raised concerns about its transmissibility, virulence, and immune escape. The aim of this letter is to address the current evidence on the origin, spread, and characteristics of Pirola, and discuss its implications for public health and vaccine development. The need for enhanced surveillance, genomic sequencing, and epidemiological studies to monitor the evolution and impact of Pirola and other SARS-CoV-2 variants are highlighted in this letter along with the importance of global cooperation and coordination to prevent and control future outbreaks of this novel coronavirus strain.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
